These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 26056952)

  • 1. Novel theranostic agents for next-generation personalized medicine: small molecules, nanoparticles, and engineered mammalian cells.
    Kojima R; Aubel D; Fussenegger M
    Curr Opin Chem Biol; 2015 Oct; 28():29-38. PubMed ID: 26056952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enzyme-Instructed Self-assembly in Biological Milieu for Theranostics Purpose.
    Huang Z; Yao Q; Wei S; Chen J; Gao Y
    Curr Med Chem; 2019; 26(8):1351-1365. PubMed ID: 28933284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted Nanotheranostics for Future Personalized Medicine: Recent Progress in Cancer Therapy.
    Jo SD; Ku SH; Won YY; Kim SH; Kwon IC
    Theranostics; 2016; 6(9):1362-77. PubMed ID: 27375785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toward a world of theranostic medication: Programming biological sentinel systems for therapeutic intervention.
    Kojima R; Aubel D; Fussenegger M
    Adv Drug Deliv Rev; 2016 Oct; 105(Pt A):66-76. PubMed ID: 27189230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanoparticle Diagnostics and Theranostics in the Clinic.
    Pallares RM; Mottaghy FM; Schulz V; Kiessling F; Lammers T
    J Nucl Med; 2022 Dec; 63(12):1802-1808. PubMed ID: 36302654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnetic mediators for ultrasound theranostics.
    Józefczak A; Kaczmarek K; Bielas R
    Theranostics; 2021; 11(20):10091-10113. PubMed ID: 34815806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A tumor multicomponent targeting chemoimmune drug delivery system for reprograming the tumor microenvironment and personalized cancer therapy.
    Sau S; Tatiparti K; Alsaab HO; Kashaw SK; Iyer AK
    Drug Discov Today; 2018 Jul; 23(7):1344-1356. PubMed ID: 29551455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Theranostics - a sure cure for cancer after 100 years?
    Song Y; Zou J; Castellanos EA; Matsuura N; Ronald JA; Shuhendler A; Weber WA; Gilad AA; Müller C; Witney TH; Chen X
    Theranostics; 2024; 14(6):2464-2488. PubMed ID: 38646648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are nanotheranostics and nanodiagnostics-guided drug delivery stepping stones towards precision medicine?
    Blau R; Krivitsky A; Epshtein Y; Satchi-Fainaro R
    Drug Resist Updat; 2016 Jul; 27():39-58. PubMed ID: 27449597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Theranostic Applications of Nanomaterials in Alzheimer's Disease: A Multifunctional Approach.
    Tripathi P; Shukla P; Bieberich E
    Curr Pharm Des; 2022; 28(2):116-132. PubMed ID: 34809540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Imaging of Cancer with Nanoparticle-Based Theranostic Probes.
    Ma YY; Jin KT; Wang SB; Wang HJ; Tong XM; Huang DS; Mou XZ
    Contrast Media Mol Imaging; 2017; 2017():1026270. PubMed ID: 29097909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Theranostic barcoded nanoparticles for personalized cancer medicine.
    Yaari Z; da Silva D; Zinger A; Goldman E; Kajal A; Tshuva R; Barak E; Dahan N; Hershkovitz D; Goldfeder M; Roitman JS; Schroeder A
    Nat Commun; 2016 Nov; 7():13325. PubMed ID: 27830705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Assessment of In-vitro and In-vivo Evaluation Methods for Theranostic Nanomaterials.
    Parashar P; Singh N; Alka ; Maurya P; Saraf SA
    Curr Pharm Des; 2022; 28(2):78-90. PubMed ID: 34348616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using Peptide Aptamer Targeted Polymers as a Model Nanomedicine for Investigating Drug Distribution in Cancer Nanotheranostics.
    Zhao Y; Houston ZH; Simpson JD; Chen L; Fletcher NL; Fuchs AV; Blakey I; Thurecht KJ
    Mol Pharm; 2017 Oct; 14(10):3539-3549. PubMed ID: 28880092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rational Design of Biomolecular Templates for Synthesizing Multifunctional Noble Metal Nanoclusters toward Personalized Theranostic Applications.
    Yu Y; Mok BY; Loh XJ; Tan YN
    Adv Healthc Mater; 2016 Aug; 5(15):1844-59. PubMed ID: 27377035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineered Hybrid Nanoparticles for On-Demand Diagnostics and Therapeutics.
    Nguyen KT; Zhao Y
    Acc Chem Res; 2015 Dec; 48(12):3016-25. PubMed ID: 26605438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smart magnetic resonance imaging-based theranostics for cancer.
    Brito B; Price TW; Gallo J; Bañobre-López M; Stasiuk GJ
    Theranostics; 2021; 11(18):8706-8737. PubMed ID: 34522208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoparticle theranostics in cardiovascular inflammation.
    MacRitchie N; Di Francesco V; Ferreira MFMM; Guzik TJ; Decuzzi P; Maffia P
    Semin Immunol; 2021 Aug; 56():101536. PubMed ID: 34862118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mammalian synthetic biology in the age of genome editing and personalized medicine.
    Ho P; Chen YY
    Curr Opin Chem Biol; 2017 Oct; 40():57-64. PubMed ID: 28628856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Porphyrins and related macrocycles: Combining photosensitization with radio- or optical-imaging for next generation theranostic agents.
    Sandland J; Malatesti N; Boyle R
    Photodiagnosis Photodyn Ther; 2018 Sep; 23():281-294. PubMed ID: 30009949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.